Cellular Dynamics: Human Cells. Endless Possibilities from Discovery to Regenerative Medicine.
CDI Notebook
TrendingDigital MediaArticlesCDI in the NewsUpcoming EventsApplications
CDI Notebook
Welcome to CDI Notebook
Trending
Special Discount on MyCell Disease and Diversity Products!

Special Discount on MyCell Disease and Diversity Products! Receive 50% off control cells with the purchase of qualifying disease model cells. Hurry! This offer ends Dec 31, 2016.

PROMOTION >>

Digital Media
Digital Medium: [Customer Story] Implementing iPSCs in Organ Regeneration Studies

Customer Story: Implementing iPSCs in Organ Regeneration Studies. Hear Dr. Amogh Sivarapatna (while a PhD candidate in Biomedical Engineering at Yale University) discuss advantages of iCell Endothelial Cells in microvascular and blood vessel engineering research.

VIDEO >>

Articles
Article: Identification of Drug–Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-derived Cardiomyocytes

Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-derived Cardiomyocytes. Read how MEA-based investigations led an in vitro effort to elucidate the mechanism underlying an adverse drug-drug interaction.

Millard DC, Strock CJ, et al. (2016) Toxicol Sci.

ARTICLE >>

Article: Interaction between Amiodarone and Hepatitis-C Virus Nucleotide Inhibitors in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes and HEK-293 Cav1.2 Over-expressing Cells

Interaction between Amiodarone and Hepatitis-C Virus Nucleotide Inhibitors in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes and HEK-293 Cav1.2 Over-expressing Cells. Discover how pharmaceutical investigators used iCell Cardiomyocytes to uncover atypical cellular mechanisms of drug-drug interactions associated with adverse clinical events.

Lagrutta A, Zeng H, et al. (2016) Toxicol Appl Pharmacol.

ARTICLE >>

CDI in the News
CDI in the News: Cell Banking in the Era of Reprogramming

Cell Banking in the Era of Reprogramming. Read about the prospective value of, as well as the challenges of establishing, donor-derived stem cell repositories in this article authored by Thomas Novak, VP Strategic Partnerships, CDI.

ARTICLE >>

Upcoming Events
Upcoming Event: Society for Neuroscience Meeting

Society for Neuroscience (Nov 12 - 16 | San Diego). Visit us at booth 2820 and these posters to discuss incorporating iCell neural products in your experimental designs.

42.09 – Phenotyping of Human iPSC-derived Dopaminergic Neurons Containing the Engineered A53T Alpha-synuclein Mutation (Nov 12, 1:00 - 5:00 pm)

301.16 – Functional Endpoint Assays to Assess Neurotoxicity with Human iPSC-derived Neurons (Nov 14, 8:00 am - 12:00 pm)

561.02 – Functional Human Neurons Derived from iPS Cells Display a Range of Unique and “Exciting” MEA Phenotypes (Nov 15, 8:00 am - 12:00 pm)

592.01 – Leveraging iPSC-derived Cortical Neurons Harboring Known Epilepsy Mutations to Advance Personalized Medicine (Nov 15, 1:00 - 5:00 pm)

CDI @ SfN >>

Applications
Applications: iForum Posters: From Ideation to Implementation

iForum Posters: From Ideation to Implementation. Review methods and results from disease modeling and compound screening/assessment studies that were fueled by iCell and MyCell products and presented by CDI during the iForum 2016 conference.

POSTERS >>

Follow UsCDI TwitterCDI LinkedInCDI FacebookCDI Youtube

© 2016 FUJIFILM Cellular Dynamics Inc., 525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
fujifilmcdi.com